Abstract
1 1 between insulin-loaded protein fibers and five anionic surfactants (sodium taurocholate, sodium 23 taurodeoxycholate, sodium glycocholate, sodium glycodeoxycholate, and sodium dodecyl sulfate), a 24 cationic surfactant (benzalkonium chloride) and a neutral surfactant (Triton X-100) were studied. The 25 anionic surfactants increased the insulin release in a concentration-dependent manner, whereas the 26 neutral surfactant had no significant effect on the release. Interestingly, only minute amounts of insulin 27 was released from the fibers when benzalkonium chloride was present. The FSP-Ins fibers appeared 28 dense after incubation with this cationic surfactant, whereas high fiber porosity was observed after 29 incubation with anionic or neutral surfactants. Contact angle measurements and staining with the 30 hydrophobic dye 8-anilino-1-naphthalenesulfonic acid indiated that the FSP-Ins fibers where 31 hydrophobic, and showed that the fiber surface properties were affected differently by the surfactants. 32
Introduction

38
Electrospun nanofibers may be applicable for a large range of biomedical applications within e.g tissue 39 engineering, regenerative medicine and drug delivery [1] [2] [3] [4] [5] . The nanofibers can be functionalized in order 40 to improve the performance in vivo, for example by addition of proteins to increase biocompatibility 6, 7 , 41 addition of a polymer to strengthen the mechanical properties 7 , addition of drugs such as antibiotics in 42 wound dressing [8] [9] [10] or growth factors or DNA for tissue engineering [11] [12] [13] [14] [15] . Even cells can be electrospun 43 to promote regeneration of new tissue [16] [17] [18] . During optimization of the fiber properties, special attention 44 should be paid to the hydrophilicity of the fibers, fiber stability and drug release profiles (in case of 45 encapsulated compounds) 12 . Drug release and stability properties are often studied in vitro in water 19, 20 , 46 phosphate buffer 21 , phosphate-buffered saline (PBS) 8, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] or other similar buffers not containing specific 47 physiologically occurring compounds 34, 35 . Depending on the application of the electrospun fibers, they 48 will be exposed to different physiological environments, which contain compounds such as bile salts, 49 proteins, and salts. However, the effects of physiologically occurring components on fiber stability and 50 drug release characteristics are rarely taken into account, for which reason the fiber performance in vitro 51 may deviate from the fiber performance in vivo. In a previous study we found that release of insulin from 52 protein fibers was increased in simulated small intestinal fluid containing lipids and sodium taurocholate 53 (ref; FSP-Ins paper). The study also demonstrated that transport of insulin across a Caco-2 cell monolayer 54 was increased due to interactions between the cells and fibers. In a study by Alborzi et al. release of folic 55 acid from alginate-pectin/polyethylene oxide electrospun fibers was studied in simulated intestinal fluid 56 containing bile extract, and the authors found that the release was decreased in the presence of bile 57 extract 36 . Sofokleous et al. studied release of amoxicillin from poly(D,L-lactide-co-glycolide) (PLGA) 58 for wound healing purposes, and found the drug release from the PLGA dressings to be different in the 59 tested media (water, simulated body fluid and PBS) 10 . Moreover, Maretschek et al. found release of 60 cytochrome C from poly(L-lactide) fibers to be increased when polysorbate was present in the release 61 medium 37 . Despite of those observations, and to the authors knowledge, no study has been dedicated to 62 detailed investigations on the potential effects in relation to the performance of electrospun fiber 63 scaffolds caused by interactions with biorelevant compounds. In the current study, we investigated how 64 biorelevant compounds affect the properties of electrospun fibers by systematically studying the 65 interactions between insulin-loaded electrospun protein fibers and four different bile salts present in the 66 human intestinal fluid (sodium taurocholate (TC), sodium taurodeoxycholate (TDC), sodium 67 glycocholate (GC) and sodium glycodeoxycholate (GDC)). In order to further elucidate the mechanism 68 accounting for the drug release induced by biological surfactants, different synthetic small molecular size 69 surfactants were included in the study: the anionic sodium dodecyl sulfate (SDS), the cationic 70 benzalkonium chloride (BC) and the neutral Triton X-100. The unpredictable effects of the different 71 surfactants on the insulin release profile, fiber porosity and fiber surface properties are reported. 72 
Materials and methods
Preparation of FSP-Ins fibers 85
Fish sarcoplasmic proteins (FSP) were isolated from fresh cod and fibers were prepared as previously 86 described 38 (Supplementary data S1, S2). A concentration of 125 mg/mL FSP was used together with 20 87 mg/mL insulin (Ins) for production of the FSP-Ins fibers. Electrospinning was conducted at room 88 temperature, and samples were stored at -20°C until further analysis. 89
In vitro release studies 90
The in vitro release of insulin from FSP-Ins fibers was performed in HBSS buffer supplemented with 10 91 mM MES (MES-HBSS, pH 6.5) containing varying amounts (1.5 mM, 3 mM or 6 mM) of surfactant 92 (TC, TDC, GC, GDC, Triton X-100, SDS or BC) during 5 h at 37°C with continuous orbital mixing. 93 FSP-Ins fibers were placed in the pre-warmed buffers at a concentration of 3.5 mg/mL and aliquots of 94 30 µl were taken from the supernatant at regular time points and replaced with buffer. The samples were 95 analyzed for contenct of insulin by using reverse phase high-pressure liquid chromatography (RP-HPLC) 96 as described below. Each experiment was carried out at least in triplicates. 97
Insulin quantification 98
Insulin concentrations were analyzed by RP-HPLC using a Prominence system (Shimadzu, Kyoto, 99 7 H2O/5% acetonitrile (AcCN)/0.1% trifluoroacetic acid (TFA) (v/v/v) and mobile phase B consisted of 102 95% AcCN/5% H2O/0.1% TFA (v/v/v). The autosampler temperature was 4°C. Insulin was eluted using 103 a linear gradient of mobile phase B from 20-50% over 3.5 min at a constant flow of 0.8 mL/min and with 104 a column temperature of 40°C. The amount of insulin was quantified as the peak area obtained at 218 105 nm (retention time 2.7 min). Limit of detection and limit of quantification were 0.2 µg/mL and 0.8 µg/mL 106 (n=3), respectively. 107
Internal fiber porosity 108
The internal porosity of FSP-Ins fibers was studied by using cryo-scanning electron microscopy (cryo-109 SEM) using a Quanta FEG 3D (FEI, Hillsboro, OR, USA) system equipped with a Leica cryo stage and 110 the EM VCT100 Cryo transport system, in combination with the MED020 freeze fracture and 111
Platinum/Carbon or Carbon coating unit (Leica, Wetzlar, Germany). The samples were incubated in 112 MES-HBSS (pH 6.5) with 6 mM surfactant (TC, SDS, Triton X-100, BC), and subsequently placed on 113 an aluminum stub that was mounted on a transport shuttle, and fixed to the stub with carbon/contact 114 medium. The sample was frozen in liquid nitrogen in order to fracture the fibers with a cooled knife 115 inside the MED020. Subsequently, the sample sublimated for 3 min and sputter-coated with platinum 116 (coating thickness 5 nm). 117
Critical micelle concentration 118
The critical micelle concentration (CMC) of the different surfactants in MES-HBSS (pH 6.5) was 119 determined according to the method described by Dominguez et al. 39 . Briefly, BZA was added to a final 120 concentration of 0.14 mM, together with varying concentrations of each of the surfactant (TC, GC, TDC, 121 GDO, Triton X-100, SDS and BC) in MES-HBSS. A total volume of 200 µl was added to a clear flat-122 bottomed 96-well UV-transparent plate (clear acrylic copolymer plate) (Corning Inc., Corning, NY, 123 8 USA), and absorption was measured at 313 nm at 37°C using a Safire 2 plate reader (Tecan Group, 124
Männedorf, Switzerland). 125
Contact angle 126
The contact angle between FSP-Ins fibers and aqueous solutions of surfactants (6 mM TC, Triton X-100, 127 SDS or BC in MES-HBSS, pH 6.5) was measured using an optical tensiometer (Theta, Attension, Espoo, 128
Finland) with a highspeed camera (3000 fps, MotionXtra N3, IDT, Tallahassee, Fl, USA). A volume of 129 7.5 µl of buffer was deposited on the fiber surface, and images were immediately recorded with 59 frame 130 per sec the first 3.4 sec, and thereafter 1 frame per second until 34 sec. The contact angle was derived 131 from the images as the angle between the tangent to the drop at the surface-liquid interface and the fiber. 132
The contact angle, calculated as the mean of the left and right contact angle, was plotted as a function of 133 time, and the initial contact angle was found by extrapolation. 134
Confocal microscopy 135
FSP-Ins fibers were placed in MES-HBSS (pH 6.5) with and without surfactants (6 mM TC, Triton X-136 100 or BC) and incubated for 3 h. After 2 h, ANS was added to a final concentration of 25 µM and the 137 incubation continued for 1 h. The fibers were transferred to a coverslip and images were obtained by 138 using a laser scanning confocal microscope (Zeiss LSM 780, Jena, Germany) applying excitation at 405 139 nm and emission measured at 489 nm. 140
Statistics 141
Statistical analysis was performed using GraphPad (GraphPad, La Jolla, CA, USA). Unpaired Student's 142 9
Results and discussion
144
Release of insulin from FSP-Ins fibers was affected by surfactants in solution 145
Insulin release from FSP-Ins fibers was studied in MES-HBSS in the absence or presence of surfactants 146 (Figure 1) . The chosen surfactants were divided into four groups, i) biologic anionic surfactants (TC, 147 TDC, GC, GDC), ii) synthetic anionic surfactant (SDS), iii) cationic surfactant (BC) and iv) neutral 148 surfactant (Triton X-100) (for the chemical structures see Supplementary information S3). The release 149 was studied at increasing surfactant concentrations, up to 6 mM, and the presence of bile salts increased 150 the release of insulin in a concentration-dependent manner (Figure 1 A-D) . No additional effect on the 151 release rate and the released amount of insulin was observed with bile salt concentrations higher than 6 152 mM (data not shown). The fibers were physically stable in the buffer during long periods of time, as no 153 change in internal structure was observed even after 2 months of incubation (Supplementary data S4) , 154 and the fibers remained non-dissolved even longer. To investigate if the effect on the insulin release 155 could be caused by surfactants in general, insulin release upon exposure to synthetic surfactants (SDS, 156 BC and Triton X-100) was analyzed in a similar manner (Figure 1 E-H) . SDS induced a similar behavior 157 as the bile salts, with increasing SDS concentrations leading to increased insulin release. However, fibers 158 that were exposed to high concentrations of SDS were degraded, as observed visually, and accordingly 159 the release of insulin continued to increase, contrary to what was observed in the presence of the bile 160 salts. The synthetic SDS is a well-known denaturing agent, and as a rule of thumb it takes 1.4 g SDS to 161 denature a gram of protein to a completely unfolded structure. Although the FSP-fibers were not saturated 162 with SDS at 6 mM SDS, degradation of the fibers clearly occurred. Further increasing the SDS 163 concentration up to 18 mM led to complete release of the entrapped insulin due to extensive fiber 164 degradation (data not shown). Complete drug release allowed for quantification of the insulin 165 encapsulation efficiency, which was found to be 98.6 ± 2.9 % (n = 3) (Ref FSP-Ins). Insulin release in 3 166 mM SDS was similar to the release in MES-HBSS, but it was noticeable that when lowering the SDS 167 concentration to 1.5 mM SDS, the insulin release decreased. The presence of the neutral surfactant, Triton 168 X-100, did not alter the insulin release profile as compared to that observed with the MES-HBSS (Figure  169 1F), and no concentration-dependency in the presence of SDS was observed. Interestingly, almost no 170 insulin was released from the FSP-Ins fibers upon incubation with the cationic surfactant BC (Figure 1  171   G) . Approximately 1 % of the encapsulated insulin was released in the 3 mM and 6 mM BC solution as 172 burst release, but after 2 h no insulin was detectable. The strength of the interactions between BC and 173
FSP-Ins fibers was investigated by transferring the FSP-Ins fibers to 12 mM SDS, after five h of 174 incubation in 3 mM BC, and surprisingly no insulin was released after addition to the SDS solution (data 175 not shown). This strongly indicated that the interaction between BC and the FSP-Ins fibers resulted in a 176
significant stabilization of the fiber structure, preventing insulin release. The differences in the way the 177 surfactants affected insulin release, suggested that i) the surfactants interacted differently with the FSP-178
Ins fibers, and ii) the interaction, and the results of the interaction, strongly depend on the properties of 179 the surfactants. The CMC of the surfactants in MES-HBSS was determined to investigate if there was 180 any relation between the CMC and the effect on release (Figure 1 H) , however, no correlation to the 181 CMC was found, which indicated that the organization of the surfactant molecules in solution did not 182 affect the behavior of the surfactants with respect to fiber interactions. In our previous study, the 183 simulated intestinal fluid also contained lipids, but the presence of lipids were found not to affect insulin 184 release (data not shown). Bovine serum albumin (BSA) is a common protein in the human body, and for 185 
194
Fiber porosity was affected by interactions with surfactant 195
In vitro release of a compound encapsulated in insoluble fibers has previously been correlated to the 196 porosity of the fibers 19, 20, 40 . From those studies it was found that the release was facilitated by a two-step 197 mechanism; desorption of the compound from the nanoporous surface of the fibers, as the rate limiting with cryo-SEM, and compared to the inner structure of the fibers before incubation (Figure 2 ). Before 207 incubation in a buffer, a small degree of porosity was observed throughout the fibers, and in some fibers 208 the porosity in the core was increased, which most likely is caused by fast evaporation of the solvent 209 ( Figure 2D ). After incubation in MES-HBSS and MES-HBSS with TC (Figure 2 A and B) the inner 210 structure of the FSP-Ins fibers became more porous, whereas the fibers that had been exposed to BC 211 became dense ( Figure 2C ). The trend in porosity correlated with insulin being released in MES-HBSS 212 and MES-HBSS with TC, whereas release in MES-HBSS containing BC was negligible. The fact that 213 the burst release in BC was almost nonexistent (Figure 1 G) , suggested that BC instantaneously interacted 214 with the surface of the fibers, and induced a stabilizing effect thus precluding insulin release and causing 215 13 the inner fiber structure to become dense. The inner structure of fibers exposed to Triton X-100 or SDS 216 were also investigated (data not shown), and porosity was observed in both cases. As with MES-HBSS 217 in the presence and absence of TC, porosity after exposure to Triton X-100 and SDS correlated with 218 insulin being released from FSP-Ins fibers in both Triton X-100 and SDS solutions. It was not possible 219 to study a potential connection between extend of insulin release and degree of porosity, since the 220 porosity made the fibers fragile and sensitive to beam damage, which resulted in partly closing of the 221 pores, which thereby prohibited quantitative analysis of the porosity. 
225
Interactions between surfactants and FSP-Ins fiber led to changes in the contact angles 226
The interactions between surfactants (TC, SDS, Triton X-100 and BC) in MES-HBSS and FSP-Ins fibers 227
were further evaluated by contact angle measurements (Figure 3) . MES-HBSS without surfactants 228 14 displayed a large contact angle of 110 ± 8 degr., which indicated that the FSP-Ins fibers were 229 hydrophobic. Addition of SDS caused no significant change in the contact angle (117 ± 7 degr.), whereas 230 addition of TC increased the contact angle to 130 ± 6 degr. The presence of BC decreased the contact 231 angle to 84 ± 21 deg. And Triton X-100 decreased the value even further to 37 ± 13 degr. The decreased 232 contact angle caused by Triton X-100 and BC suggested that interactions between Triton X-100, or BC, 
242
Representative images of a drop of buffer (MES-HBSS with or without surfactants) on FSP-Ins fibers (C).
243
Surface properties of the FSP-Ins fibers were affected by interactions with surfactants 244
The hydrophobic nature of the FSP-Ins fibers was studied by ANS fluorescence (Figure 4) . ANS is 245 widely used to visualize hydrophobic regions in e.g. fibrillar aggregates and fibers, as its fluorescence is 246 enhanced when ANS interacts with hydrophobic environments 42, 43 . Increase in fluorescence intensity can 247 thus be ascribed to the exposure of hydrophobic pockets to ANS molecules favouring the binding. 
272
Conclusion
273
The results presented in this study clearly indicate that biorelevant compounds interact with electrospun 274 fibers. The interactions between surfactants in solution and electrospun protein fibers were found to 275 significantly influence the release of entrapped cargo, the fiber stability, porosity and the fiber surface 276 properties. Anionic surfactants were shown to have a concentration-dependent effect on insulin release, 277 whereas addition of Triton X-100 did not cause a significant change in the amount released, and in MES-278 HBSS with BC, only negligible amounts of insulin were released. Cryo-SEM images of the fibers after 279 incubation with the surfactants showed a correlation between release of cargo and increased porosity of 280 the fibers, in the sense that when insulin was released, fiber porosity was observed. Contact angle 281 measurements revealed that the surfactants had a significant influence on wetting of the fibers; for anionic 282 surfactants a small increase in the contact angle was observed, whereas the presence of the cationic 283 surfactant, and especially the neutral surfactant, decreased the contact angle considerably. Interactions 284 between fibers and surfactants were further elucidated, by decreased levels of interactions with the 285 hydrophobic pocket fluorophore, ANS, after fiber incubation with neutral or cationic surfactants, as 286 compared to anionic or no surfactants. Overall, this study emphasizes the importance of taking into 287 account biologically relevant components, such as bile salts and proteins, with which electrospun fibers 288 may be exposed to when used for tissue engineering, wound healing, drug delivery and other biomedical 289 
